- Abdomen
- Acinar cells
- Acquired mutations
- Active immunotherapy
- Acupuncture
- Acute pain
- Adenocarcinoma
- Adjuvant drug
- Adjuvant therapy
- Advance directives
- Alcohol nerve block
- Alternative therapy
- Ampulla of Vater
- Analgesic
- Angiogenesis
- Anticonvulsants
- Antidepressants
- Antiemetics
- Benign
- Benign
- Bequests
- Bile
- Bioelectromagnetic-based therapy
- Biofield therapy
- Biopsy
- BRCA1 gene
- BRCA2 gene
- Brush biopsy
- Cancer
- Cancer antigen 19-9 (CA 19-9)
- Cancer stem cells
- Carcinoembryonic antigen (CEA)
- Caregivers
- Catheter
- Celiac plexus
- Celiac plexus
- Charitable Gift Annuities (CGA)
- Charitable Remainder Unitrusts (CRUT)
- Chemoradiation
- Chemotherapy
- Chemotherapy
- Chemotherapy
- Chiropractic
- Chronic pain
- Chronic pancreatitis
- Clinical trial
- Co-existing condition
- Complementary therapy
- Computed tomography (CT) scan
- Constipation
- Contrast agent
- Coping
- Corticosteroids
- Diabetes mellitus
- Distal pancreatectomy
- DNA
- Donor-Advised Funds (DAF)
- Dual-phase helical CT scan
- Duct
- Duodenum
- Durable power of attorney for healthcare
- Efficacy
- Efficacy
- Endocrine gland
- Endocrinologist
- Endoscope
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Endoscopic ultrasonography (EUS)
- Enzymes
- Esophagus
- Exocrine gland
- External beam radiation therapy
- Familial atypical multiple mole melanoma (FAMMM) syndrome
- Familial breast cancer syndrome
- Fine-needle aspiration (FNA) biopsy
- First-degree relative
- Gallbladder
- Gastroenterologist
- Gene
- Gifts of Life Insurance
- Gifts of personal items (art and other collectibles)
- Gifts of Real Estate
- Gifts of stock
- Healthcare proxy
- Hepatitis
- Hereditary nonpolyposis colon cancer (HNPCC; Lynch syndrome)
- Hereditary pancreatitis
- Homeopathic medicine
- Hospice
- Ileum
- Imaging tests
- Informed consent
- Inherited mutations
- Insulin
- Integrative therapy
- Intraductal papillary mucinous neoplasm (IPMN)
- Intrathecal injection
- Intravenous injection
- Islets of Langerhans
- Jaundice
- Jejunum
- KRAS oncogene
- Laparoscope
- Laparoscopic ultrasonography
- Laparoscopy
- Living will
- Lymph nodes
- Lymphatic fluid
- Lymphatic system
- Lymphocyte
- Magnetic resonance cholangiopancreatography (MRCP)
- Magnetic resonance imaging (MRI)
- Malignant
- Malignant
- Medical oncologist
- Melanoma
- Metastatic
- Multidetector row helical CT (MDCT) scan
- Multidisciplinary care
- Multiple endocrine neoplasia type 1 syndrome (MEN1; Wermer’s syndrome)
- Mutations
- Naturopathic medicine
- Neoadjuvant therapy
- Neoplasm
- Nerve block
- Neuroablation
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Oncology nurses
- Oncology social workers
- Opioids
- Osteopathic
- Palliative care
- Palliative surgery
- Pancreas
- Pancreatic duct
- Pancreatic enzymes
- Pancreatic intraepithelial neoplasia (PanIN)
- Pancreaticoduodenectomy
- Pancreatitis
- Patency
- Pathologist
- Patient-controlled analgesia (PCA)
- Peritoneum
- Peutz-Jeghers syndrome (PJS)
- Phase 1
- Phase 2
- Phase 3
- Phases of clinical trials
- Physician assistant
- Placebo
- Planned Giving
- Pooled Income Funds
- Positron emission tomography (PET scan)
- Power of attorney
- Protein
- Proven therapy
- Pylorus-preserving Whipple procedure
- Quackery
- Qualified Charitable Gift Distributions (QCD)
- Questionable therapy
- Radiation oncologist
- Radiation therapy
- Radioactive
- Radioactive glucose
- Radiologist
- Radiotherapy
- Risk factors
- Single-agent drug
- Spleen
- Staging cancer
- Stent
- Stroma
- Subcutaneous
- Supportive care
- Symptoms
- Systemic treatment
- Targeted therapy
- TNM system
- Total pancreatectomy
- Transdermal
- Transfers of IRA or other retirement account funds
- Tumor markers
- Ultrasound
- Unconventional therapy
- Whipple procedure
